NCT00605423View on ClinicalTrials.gov

The MAP Study: Fluocinolone Acetonide (FA)/Medidur (TM) for Age Related Macular Degeneration (AMD) Pilot

PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Age Related Macular Degeneration
Interventions
DRUG

Fluocinolone Acetonide/Medidur

0.2 ug/day implant

DRUG

Fluocinolone Acetonide/Medidur

0.5 ug/day implant

Trial Locations (1)

21287

Wilmer Eye Institute, Johns Hopkins University, Baltimore

Sponsors

Collaborators (1)

Alimera Sciences
All Listed Sponsors
collaborator

Alimera Sciences

INDUSTRY

collaborator

pSiVida Limited

INDUSTRY

lead

Johns Hopkins University

OTHER